Bright Minds Biosciences Inc.

General ticker "DRUG" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $375.6M (TTM average)

Bright Minds Biosciences Inc. follows the US Stock Market performance with the rate: 58.2%.

Estimated limits based on current volatility of 5.5%: low 76.74$, high 85.61$

Factors to consider:

  • Total employees count: 2 as of 2022
  • Current price 3882.3% above estimated high
  • Earnings for 18 months up through Q2 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [0.63$, 2.03$]
  • 2025-09-30 to 2026-09-30 estimated range: [0.59$, 1.87$]

Financial Metrics affecting the DRUG estimates:

  • Positive: with PPE of -2.4 at the end of fiscal year the price was neutral
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of 0 > -0.60
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0 <= 0.01

Similar symbols

Short-term DRUG quotes

Long-term DRUG plot with estimates

Financial data

YTD 2023-09-30 2024-09-30 2025-09-30
Operating Revenue CA$0.00MM CA$0.00MM CA$0.00MM
Operating Expenses CA$7.39MM CA$2.82MM CA$13.94MM
Operating Income CA$-7.39MM CA$-2.82MM CA$-13.94MM
Non-Operating Income CA$0.01MM CA$0.02MM CA$1.71MM
R&D Expense CA$5.00MM CA$1.18MM CA$11.08MM
Income(Loss) CA$-7.37MM CA$-2.80MM CA$-12.23MM
Net Income(Loss)* CA$-7.37MM CA$-2.80MM CA$-12.23MM
Stockholders Equity CA$6.60MM CA$5.54MM CA$82.04MM
Assets CA$6.88MM CA$6.10MM CA$84.42MM
Operating Cash Flow CA$-7.02MM CA$-1.85MM CA$-8.69MM
Financing Cash Flow CA$2.19MM CA$0.81MM CA$85.57MM
Earnings Per Share** CA$-1.98 CA$-0.65 CA$-1.78

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.